2010 Press Releases

FDA Advisory Committee Recommends Approval to Expand Use of LAP-BAND® Adjustable Gastric Banding System for Obese Adults  

New treatment targets natural tears for dry eyes  

Discover the Power of the Lash  

Allergan Reports Third Quarter 2010 Operating Results  

ADDING MULTIMEDIA BOTOX(R) (onabotulinumtoxinA) FDA Approved as Prophylactic Treatment Option for Adult Chronic Migraine Sufferers  

BOTOX(R) (onabotulinumtoxinA) FDA Approved as Prophylactic Treatment Option for Adult Chronic Migraine Sufferers  

Allergan Announces Quarterly Conference Call  

Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye  

Allergan Resolves United States Government Investigation of Past Sales and Marketing Practices Relating to Certain Therapeutic Uses of BOTOX(R)  

Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients  

Allergan Reports Second Quarter 2010 Operating Results  

BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine  

Allergan Announces Quarterly Conference Call  

Lifestyle Designer Kathy Ireland, Professional Ballroom Dancer Chelsie Hightower and Style Guide Bobbie Thomas Lead the LATISSE(R) Wishes Challenge Campaign to Benefit the Make-A-Wish Foundation(R)  

Allergan Receives CEO Cancer Gold Standard(TM) Accreditation  

Allergan Receives FDA Approval for ZYMAXID(TM) Ophthalmic Solution  

Allergan, Inc. Launches Public Awareness and Advocacy Campaign to Urge Greater Attention to Critical Need for Both Prevention and Treatment to Effectively Address Adult Obesity  

Allergan Reports First Quarter 2010 Operating Results  

Allergan Announces Quarterly Conference Call  

Allergan and Serenity Pharmaceuticals Enter into Global Agreement for the Treatment of Nocturia